-+ 0.00%
-+ 0.00%
-+ 0.00%

United Therapeutics CEO Martine Rothblatt reports sale of 9,500 common shares worth $5.04 million

PUBT·07/27/2026 10:56:42
Listen to the news
United Therapeutics CEO Martine Rothblatt reports sale of 9,500 common shares worth $5.04 million
  • United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at USD 135.42 on July 24, 2026.
  • A related trust sold 9,500 shares the same day at weighted-average prices around USD 528.72 to USD 535.03.
  • The trust reported 324,443 shares beneficially owned following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000106), on July 27, 2026, and is solely responsible for the information contained therein.